We’re delighted to announce Lisa Walker as the new CEO of Neuroendocrine Cancer UK.
Lisa brings over 20 years of experience in healthcare and charity leadership, including co-founding and leading an organisation supporting people with Crohn’s disease.
Having been part of the Neuroendocrine Cancer UK team for more than three years, Lisa has already made a significant impact – raising awareness among healthcare professionals, enhancing research initiatives, and deepening engagement across our community.
Her commitment to improving the lives and outcomes of those affected by neuroendocrine cancer is both professional and deeply personal.
Lisa shared:
“I’m incredibly proud and excited to be leading Neuroendocrine Cancer UK at such a pivotal time. Working with Catherine has been a privilege, and I want to recognise the outstanding work she has done in establishing and developing the charity over the past 20 years. I’m committed to carrying that legacy forward and improving how neuroendocrine cancer is diagnosed and treated across the UK.”
As we begin this new chapter, we want to thank our community for your continued support – together, we’ll keep driving forward our mission to improve awareness, care, and outcomes for everyone affected by neuroendocrine cancer.